Health Care: Drugs

Pacira Pharmaceuticals Inc (PCRX: NASDAQ)

$104.13 2.83 | 2.79%
10/23/14 - 04:00 PM ET
Company Profile
Price and Volume
Recent Price 101.30
52 Week High 109.94
52 Week Low 45.68
Avg. Daily Vol. (Mil) 0.47
Beta (3 year) 1.63
Share Related Items
Mkt Cap (Mil) 3,635.85
Shares Out (Mil) 35.89
Float (Mil) 19.79
Dividend Information
Yield % 0.00
Annual Dividend 0.00
Payout Ratio 0.00
Financial Strength
Quick Ratio 1.40
Current Ratio 1.60
LT Debt/ Equity 0.00
Total Debt / Equity 0.68
Valuation Ratios
Price Earnings n.a.
Price/Sales 25.85
Price/Book 24.57
Price/Cash Flow -118.00
Per Share Data
Earnings -1.28
Sales 3.92
Book Value 4.12
Cash Flow -0.85
Business Summary
Pacira Pharmaceuticals, Inc. is a specialty pharmaceutical company. The Company is engaged in the development, commercialization and manufacture of proprietary pharmaceutical products for use in hospitals and ambulatory surgery centers.
General Information
5 Sylvan Way
Suite 100
Parsippany, NJ 07054
www.pacira.com
Industry : Drugs
Sector: Health Care
Employees: 308
CEO: David M. Stack
Short Interest
Current Month (Mil) 3.81
Previous Month (Mil) 4.08
Short Interest Ratio (Days) 7.10
Management Effectiveness
Return on Equity n.a.
Return on Assets -14.80
Return on Investments -29.20
Profitability
Gross Margin 58.30
EBIT Margin -25.10
Profit Margin -30.80

Portfolios with PCRX

Latest PCRX Headlines from TheStreet

More Financial News for PCRX

Press Releases for PCRX

See All Press Releases

Partner Headlines for PCRX

brokerage partners
connect with Stockpickr
Fan us on FaceBook
Follow us on Twitter